Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation.

Wiebe J, Hofmann FJ, Dörr O, Bauer T, Boeder N, Liebetrau C, Blachutzik F, Möllmann H, Elsässer A, Achenbach S, Hamm CW, Nef HM.

Catheter Cardiovasc Interv. 2020 Mar 18. doi: 10.1002/ccd.28843. [Epub ahead of print]

PMID:
32187817
2.

High-Content Immunophenotyping and Hierarchical Clustering Reveal Sources of Heterogeneity and New Surface Markers of Human Blood Monocyte Subsets.

Hoffmann J, Fišer K, Liebetrau C, Staubach N, Kost D, Voss S, Heiden AZ, Dörr O, Lipps C, Nef HM, Möllmann H, Hamm CW, Keller T, Troidl C.

Thromb Haemost. 2020 Jan;120(1):141-155. doi: 10.1055/s-0039-1700871. Epub 2019 Dec 30.

PMID:
31887780
3.

Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary Syndromes.

Yamamoto E, Yonetsu T, Kakuta T, Soeda T, Saito Y, Yan BP, Kurihara O, Takano M, Niccoli G, Higuma T, Kimura S, Minami Y, Ako J, Adriaenssens T, Boeder NF, Nef HM, Fracassi F, Sugiyama T, Lee H, Crea F, Kimura T, Fujimoto JG, Fuster V, Jang IK.

J Am Heart Assoc. 2019 Nov 5;8(21):e012322. doi: 10.1161/JAHA.119.012322. Epub 2019 Oct 23.

4.

Mitral valve leaflet repair with the new PASCAL system: early real-world data from a German multicentre experience.

Kriechbaum SD, Boeder NF, Gaede L, Arnold M, Vigelius-Rauch U, Roth P, Sander M, Böning A, Bayer M, Elsässer A, Möllmann H, Hamm CW, Nef HM.

Clin Res Cardiol. 2019 Aug 26. doi: 10.1007/s00392-019-01538-3. [Epub ahead of print]

PMID:
31451915
5.

Everolimus- vs. novolimus-eluting bioresorbable scaffolds in patients with acute coronary syndrome.

Nef HM, Wiebe J, Schmidt G, Möllmann H, Boeder NF, Dörr O, Bauer T, Blachutzik F, Liebetrau C, Elsässer A, Foin N, Hamm CW.

Herz. 2019 Jun 17. doi: 10.1007/s00059-019-4822-7. [Epub ahead of print]

PMID:
31209520
6.

Predictive value of preprocedural procalcitonin for short- and long-term mortality after transfemoral transcatheter aortic valve implantation.

Keranov S, Kim WK, Arsalan M, Renker M, Keller T, Bauer T, Dörr O, Nef HM, Gaede L, Möllmann H, Walther T, Hamm CW, Liebetrau C.

Heart Vessels. 2019 Dec;34(12):1993-2001. doi: 10.1007/s00380-019-01448-4. Epub 2019 Jun 7.

PMID:
31175405
7.

Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-years Results from the GABI-R Registry.

Gori T, Achenbach S, Riemer T, Mehilli J, Nef HM, Naber C, Richardt G, Wöhrle J, Zahn R, Neumann T, Kastner J, Schmermund A, Hamm C, Münzel T.

J Clin Med. 2019 May 30;8(6). pii: E767. doi: 10.3390/jcm8060767.

8.

Incidental Finding of Strut Malapposition Is a Predictor of Late and Very Late Thrombosis in Coronary Bioresorbable Scaffolds.

Boeder NF, Weissner M, Blachutzik F, Ullrich H, Anadol R, Tröbs M, Münzel T, Hamm CW, Dijkstra J, Achenbach S, Nef HM, Gori T.

J Clin Med. 2019 Apr 27;8(5). pii: E580. doi: 10.3390/jcm8050580.

9.

Calcified Plaques in Patients With Acute Coronary Syndromes.

Sugiyama T, Yamamoto E, Fracassi F, Lee H, Yonetsu T, Kakuta T, Soeda T, Saito Y, Yan BP, Kurihara O, Takano M, Niccoli G, Crea F, Higuma T, Kimura S, Minami Y, Ako J, Adriaenssens T, Boeder NF, Nef HM, Fujimoto JG, Fuster V, Finn AV, Falk E, Jang IK.

JACC Cardiovasc Interv. 2019 Mar 25;12(6):531-540. doi: 10.1016/j.jcin.2018.12.013.

10.

Effect of Plaque Composition, Morphology, and Burden on DESolve Novolimus-Eluting Bioresorbable Vascular Scaffold Expansion and Eccentricity - An Optical Coherence Tomography Analysis.

Boeder NF, Dörr O, Bauer T, Elsässer A, Möllmann H, Achenbach S, Hamm CW, Nef HM.

Cardiovasc Revasc Med. 2019 Jun;20(6):480-484. doi: 10.1016/j.carrev.2018.07.030. Epub 2018 Aug 2.

PMID:
30638889
11.

Incidence and outcome of peri-procedural cardiogenic shock: results from the international Euro Heart Survey PCI registry.

Weipert KF, Bauer T, Nef HM, Hochadel M, Weidinger F, Gitt AK, Zeymer U, Hamm CW.

Eur Heart J Acute Cardiovasc Care. 2020 Mar;9(2):120-127. doi: 10.1177/2048872618822460. Epub 2019 Jan 8.

PMID:
30618264
12.

Appropriate use criteria for optical coherence tomography guidance in percutaneous coronary interventions : Recommendations of the working group of interventional cardiology of the Netherlands Society of Cardiology.

IJsselmuiden AJJ, Zwaan EM, Oemrawsingh RM, Bom MJ, Dankers FJWM, de Boer MJ, Camaro C, van Geuns RJM, Daemen J, van der Heijden DJ, Jukema JW, Kraaijeveld AO, Meuwissen M, Schölzel BE, Pundziute G, van der Harst P, van Ramshorst J, Dirksen MT, Zivelonghi C, Agostoni P, van der Heyden JAS, Wykrzykowska JJ, Scholte MJ, Nef HM, Kofflard MJM, van Royen N, Alings M, Kedhi E.

Neth Heart J. 2018 Oct;26(10):473-483. doi: 10.1007/s12471-018-1143-z. Review.

13.

International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.

Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C.

Eur Heart J. 2018 Jun 7;39(22):2032-2046. doi: 10.1093/eurheartj/ehy076.

14.

International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management.

Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C.

Eur Heart J. 2018 Jun 7;39(22):2047-2062. doi: 10.1093/eurheartj/ehy077.

15.

Predictors of early scaffold thrombosis: results from the multicenter prospective German-Austrian ABSORB RegIstRy.

Wöhrle J, Nef HM, Naber C, Achenbach S, Riemer T, Mehilli J, Münzel T, Schneider S, Markovic S, Seeger J, Rottbauer W, Pfannebecker T, Richardt G, Zahn R, Gori T, Kastner J, Schmermund A, Hamm CW; GABI-R Study Group.

Coron Artery Dis. 2018 Aug;29(5):389-396. doi: 10.1097/MCA.0000000000000618.

PMID:
29649071
16.

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R).

Nef HM, Wiebe J, Kastner J, Mehilli J, Muenzel T, Naber C, Neumann T, Richardt G, Schmermund A, Woehrle J, Zahn R, Riemer T, Achenbach S, Hamm CW.

EuroIntervention. 2017 Dec 20;13(11):1311-1318. doi: 10.4244/EIJ-D-17-00330.

17.

Identification of Periprocedural Myocardial Infarction Using a High-Sensitivity Troponin I Assay in Patients Who Underwent Transcatheter Aortic Valve Implantation.

Liebetrau C, Kim WK, Meyer A, Arsalan M, Gaede L, Blumenstein JM, Fischer-Rasokat U, Wolter JS, Dörr O, Schillinger S, Troidl C, Nef HM, Hamm CW, Walther T, Möllmann H.

Am J Cardiol. 2017 Oct 1;120(7):1180-1186. doi: 10.1016/j.amjcard.2017.06.069. Epub 2017 Jul 14.

PMID:
28826900
18.

Long-term clinical outcome after implantation of the self-expandable STENTYS stent in a large, multicenter cohort.

Gaede L, Liebetrau C, Dörr O, Blumenstein J, Elsässer A, Hamm CW, Möllmann H, Schlundt C, Nef HM, Achenbach S.

Coron Artery Dis. 2017 Nov;28(7):588-596. doi: 10.1097/MCA.0000000000000533.

PMID:
28704242
19.

Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.

Boeder NF, Dörr O, Bauer T, Mattesini A, Elsässer A, Liebetrau C, Achenbach S, Hamm CW, Nef HM.

Int J Cardiol. 2017 Nov 1;246:74-79. doi: 10.1016/j.ijcard.2017.05.087. Epub 2017 May 24.

PMID:
28579164
20.

Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease: A Matched Comparison.

Wiebe J, Dörr O, Ilstad H, Husser O, Liebetrau C, Boeder N, Bauer T, Möllmann H, Kastrati A, Hamm CW, Nef HM.

JACC Cardiovasc Interv. 2017 Mar 13;10(5):477-485. doi: 10.1016/j.jcin.2016.11.034. Epub 2017 Feb 15.

21.

Outcome After Long-segment Stenting With Everolimus-eluting Bioresorbable Scaffolds Focusing on the Concept of Overlapping Implantation.

Wiebe J, Dörr O, Liebetrau C, Bauer T, Wilkens E, Ilstad H, Boeder N, Elsässer A, Möllmann H, Hamm CW, Nef HM.

Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1144-1151. doi: 10.1016/j.rec.2016.08.012. Epub 2016 Oct 27. English, Spanish.

PMID:
28134094
22.

Bioresorbable scaffold implantation in patients with indication for oral anticoagulation: A propensity matched analysis.

Boeder NF, Johnson V, Dörr O, Wiebe J, Elsässer A, Möllmann H, Hamm CW, Nef HM, Bauer T.

Int J Cardiol. 2017 Mar 15;231:73-77. doi: 10.1016/j.ijcard.2016.11.280. Epub 2016 Nov 24.

PMID:
27899203
23.

Endocarditis after interventional repair of the mitral valve: Review of a dilemma.

Boeder NF, Dörr O, Rixe J, Weipert K, Bauer T, Bayer M, Hamm CW, Nef HM.

Cardiovasc Revasc Med. 2017 Mar;18(2):141-144. doi: 10.1016/j.carrev.2016.11.003. Epub 2016 Nov 10. Review.

PMID:
27890554
24.

A new novolimus-eluting bioresorbable coronary scaffold: Present status and future clinical perspectives.

Nef HM, Wiebe J, Foin N, Blachutzik F, Dörr O, Toyloy S, Hamm CW.

Int J Cardiol. 2017 Jan 15;227:127-133. doi: 10.1016/j.ijcard.2016.11.033. Epub 2016 Nov 9. Review.

PMID:
27863289
25.

Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction.

Liebetrau C, Gaede L, Wolter JS, Homann J, Meyer A, Dörr O, Nef HM, Troidl C, Hamm CW, Möllmann H, Richards AM, Pemberton CJ.

Biomarkers. 2017 May - Jun;22(3-4):304-310. doi: 10.1080/1354750X.2016.1252965. Epub 2016 Nov 22.

PMID:
27775442
26.

[Bifurcation lesions : How should they be assessed and treated?]

Nef HM, Dörr O, Möllmann H, Elsässer A.

Herz. 2016 Nov;41(7):572-578. Review. German.

PMID:
27717991
27.

Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.

Blachutzik F, Boeder N, Wiebe J, Mattesini A, Dörr O, Most A, Bauer T, Röther J, Tröbs M, Schlundt C, Achenbach S, Hamm CW, Nef HM.

Clin Res Cardiol. 2017 Apr;106(4):271-279. doi: 10.1007/s00392-016-1048-z. Epub 2016 Oct 18.

PMID:
27757522
28.

Thebesian veins as drainage to the ventricle: A case report.

F Boeder N, Nef HM, Bauer T.

Cardiovasc Revasc Med. 2017 Apr - May;18(3):213-214. doi: 10.1016/j.carrev.2016.09.007. Epub 2016 Sep 30.

PMID:
27743821
29.

N-terminal fragment of cardiac myosin binding protein-C triggers pro-inflammatory responses in vitro.

Lipps C, Nguyen JH, Pyttel L, Lynch TL 4th, Liebetrau C, Aleshcheva G, Voss S, Dörr O, Nef HM, Möllmann H, Hamm CW, Sadayappan S, Troidl C.

J Mol Cell Cardiol. 2016 Oct;99:47-56. doi: 10.1016/j.yjmcc.2016.09.003. Epub 2016 Sep 8.

30.

A new novolimus-eluting bioresorbable scaffold for large coronary arteries: an OCT study of acute mechanical performance.

Boeder NF, Koepp T, Dörr O, Bauer T, Mattesini A, Elsässer A, Möllmann H, Blachutzik F, Achenbach S, Ghanem A, Hamm CW, Nef HM.

Int J Cardiol. 2016 Oct 1;220:706-10. doi: 10.1016/j.ijcard.2016.06.160. Epub 2016 Jun 26.

PMID:
27393853
31.

Everolimus-eluting bioresorbable scaffold implantation for the treatment of bifurcation lesions - Implications from early clinical experience during daily practice.

Wiebe J, Dörr O, Bauer T, Liebetrau C, Boeder N, Möllmann H, Hamm CW, Nef HM.

Cardiovasc Revasc Med. 2016 Jul-Aug;17(5):313-7. doi: 10.1016/j.carrev.2016.03.011. Epub 2016 Mar 28.

PMID:
27085220
32.

Reference Values and Release Kinetics of B-Type Natriuretic Peptide Signal Peptide in Patients with Acute Myocardial Infarction.

Liebetrau C, Gaede L, Dörr O, Blumenstein J, Rosenburg S, Hoffmann J, Troidl C, Hamm CW, Nef HM, Möllmann H, Richards AM, Pemberton CJ.

Clin Chem. 2015 Dec;61(12):1532-9. doi: 10.1373/clinchem.2015.244327. Epub 2015 Oct 27.

PMID:
26506995
33.

Bioresorbable scaffolds in daily clinical routine: a practical review of all-comers results.

Wiebe J, Hamm CW, Nef HM.

Curr Opin Cardiol. 2015 Nov;30(6):650-6. doi: 10.1097/HCO.0000000000000229. Review.

PMID:
26447503
34.

Use and outcome of thrombus aspiration in patients with primary PCI for acute ST-elevation myocardial infarction: results from the multinational Euro Heart Survey PCI Registry.

Weipert KF, Bauer T, Nef HM, Möllmann H, Hochadel M, Marco J, Weidinger F, Zeymer U, Gitt AK, Hamm CW.

Heart Vessels. 2016 Sep;31(9):1438-45. doi: 10.1007/s00380-015-0754-1. Epub 2015 Oct 5.

PMID:
26438532
35.

Impact of the learning curve on procedural results and acute outcome after percutaneous coronary interventions with everolimus-eluting bioresorbable scaffolds in an all-comers population.

Wiebe J, Liebetrau C, Dörr O, Wilkens E, Bauer T, Elsässer A, Achenbach S, Möllmann H, Hamm CW, Nef HM.

Cardiovasc Revasc Med. 2015 Dec;16(8):455-60. doi: 10.1016/j.carrev.2015.09.003. Epub 2015 Sep 10.

PMID:
26428450
36.

Fate of Patients With Coronary Perforation Complicating Percutaneous Coronary Intervention (from the Euro Heart Survey Percutaneous Coronary Intervention Registry).

Bauer T, Boeder N, Nef HM, Möllmann H, Hochadel M, Marco J, Weidinger F, Zeymer U, Gitt AK, Hamm CW.

Am J Cardiol. 2015 Nov 1;116(9):1363-7. doi: 10.1016/j.amjcard.2015.07.056. Epub 2015 Aug 14.

PMID:
26341189
37.

Implantation of everolimus-eluting bioresorbable scaffolds in a diabetic all-comers population.

Wiebe J, Gilbert F, Dörr O, Liebetrau C, Wilkens E, Bauer T, Elsässer A, Möllmann H, Hamm CW, Nef HM.

Catheter Cardiovasc Interv. 2015 Nov 15;86(6):975-81. doi: 10.1002/ccd.26140. Epub 2015 Aug 13.

PMID:
26269391
38.

New potential diagnostic biomarkers for pulmonary hypertension.

Tiede SL, Gall H, Dörr O, dos Santos Guilherme M, Troidl C, Liebetrau C, Voss S, Voswinckel R, Schermuly RT, Seeger W, Grimminger F, Zeiher AM, Dimmeler S, Möllmann H, Hamm CW, Ghofrani HA, Nef HM.

Eur Respir J. 2015 Nov;46(5):1390-6. doi: 10.1183/13993003.00187-2015. Epub 2015 Aug 6. Erratum in: Eur Respir J. 2016 Sep;48(3):962.

39.

Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay.

Liebetrau C, Weber M, Tzikas S, Palapies L, Möllmann H, Pioro G, Zeller T, Beiras-Fernandez A, Bickel C, Zeiher AM, Lackner KJ, Baldus S, Nef HM, Blankenberg S, Hamm CW, Münzel T, Keller T.

BMC Med. 2015 Jul 27;13:169. doi: 10.1186/s12916-015-0410-8.

40.

Epidemiology and pathophysiology of Takotsubo syndrome.

Akashi YJ, Nef HM, Lyon AR.

Nat Rev Cardiol. 2015 Jul;12(7):387-97. doi: 10.1038/nrcardio.2015.39. Epub 2015 Apr 7. Review.

41.

Trapped cardioverter-defibrillator lead after interventional closure of an iatrogenic atrial septal defect after catheter-based mitral valve repair with the MitraClip system.

Boeder NF, Schmitt J, Erkapic D, Rixe J, Nef HM.

Int J Cardiol. 2015 Apr 1;184:412-3. doi: 10.1016/j.ijcard.2015.02.046. Epub 2015 Feb 25. No abstract available.

PMID:
25746496
42.

Implantation of a novolimus-eluting bioresorbable scaffold with a strut thickness of 100 µm showing evidence of self-correction.

Wiebe J, Bauer T, Dörr O, Möllmann H, Hamm CW, Nef HM.

EuroIntervention. 2015 Jun;11(2):204. doi: 10.4244/EIJY15M02_01. No abstract available.

43.

Comorbidities frequency in Takotsubo syndrome: an international collaborative systematic review including 1109 patients.

Pelliccia F, Parodi G, Greco C, Antoniucci D, Brenner R, Bossone E, Cacciotti L, Capucci A, Citro R, Delmas C, Guerra F, Ionescu CN, Lairez O, Larrauri-Reyes M, Lee PH, Mansencal N, Marazzi G, Mihos CG, Morel O, Nef HM, Nunez Gil IJ, Passaseo I, Pineda AM, Rosano G, Santana O, Schneck F, Song BG, Song JK, Teh AW, Ungprasert P, Valbusa A, Wahl A, Yoshida T, Gaudio C, Kaski JC.

Am J Med. 2015 Jun;128(6):654.e11-9. doi: 10.1016/j.amjmed.2015.01.016. Epub 2015 Feb 4. Review.

PMID:
25660245
44.

Pulmonary vascular remodeling before and after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a cardiac magnetic resonance study.

Rolf A, Rixe J, Kim WK, Guth S, Körlings N, Möllmann H, Nef HM, Liebetrau C, Krombach G, Kramm T, Mayer E, Hamm CW.

Int J Cardiovasc Imaging. 2015 Mar;31(3):613-9. doi: 10.1007/s10554-014-0580-z. Epub 2014 Dec 18.

PMID:
25519191
45.

Current status of bioresorbable scaffolds in the treatment of coronary artery disease.

Wiebe J, Nef HM, Hamm CW.

J Am Coll Cardiol. 2014 Dec 16;64(23):2541-51. doi: 10.1016/j.jacc.2014.09.041. Review.

46.

Right ventricular adaptation to pulmonary pressure load in patients with chronic thromboembolic pulmonary hypertension before and after successful pulmonary endarterectomy--a cardiovascular magnetic resonance study.

Rolf A, Rixe J, Kim WK, Börgel J, Möllmann H, Nef HM, Liebetrau C, Kramm T, Guth S, Krombach GA, Mayer E, Hamm CW.

J Cardiovasc Magn Reson. 2014 Dec 5;16:96. doi: 10.1186/s12968-014-0096-7.

47.

Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion.

Wiebe J, Liebetrau C, Dörr O, Most A, Weipert K, Rixe J, Bauer T, Möllmann H, Elsässer A, Hamm CW, Nef HM.

Int J Cardiol. 2015 Jan 20;179:90-4. doi: 10.1016/j.ijcard.2014.10.032. Epub 2014 Nov 7.

PMID:
25464422
48.

[Procedural aspects in primary PCI: arterial access, stent selection, thrombectomy and treatment of non-culprit lesions].

Boeder NF, Hamm CW, Nef HM.

Herz. 2014 Sep;39(6):685-91. doi: 10.1007/s00059-014-4133-y. German.

PMID:
25070211
49.

Cortisol awakening and stress response, personality and psychiatric profiles in patients with takotsubo cardiomyopathy.

Kastaun S, Schwarz NP, Juenemann M, Yeniguen M, Nef HM, Moellmann H, Hamm CW, Sammer G, Hennig J, Bachmann G, Gerriets T.

Heart. 2014 Nov;100(22):1786-92. doi: 10.1136/heartjnl-2014-305745. Epub 2014 Jul 1.

PMID:
24986894
50.

High-sensitivity cardiac troponin T and copeptin assays to improve diagnostic accuracy of exercise stress test in patients with suspected coronary artery disease.

Liebetrau C, Gaede L, Dörr O, Hoffmann J, Wolter JS, Weber M, Rolf A, Hamm CW, Nef HM, Möllmann H.

Eur J Prev Cardiol. 2015 Jun;22(6):684-92. doi: 10.1177/2047487314529691. Epub 2014 Apr 3.

PMID:
24699335

Supplemental Content

Support Center